986 related articles for article (PubMed ID: 16364850)
21. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
[TBL] [Abstract][Full Text] [Related]
22. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
[TBL] [Abstract][Full Text] [Related]
23. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
24. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
[TBL] [Abstract][Full Text] [Related]
25. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
26. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation.
Gracin N; Johnson MR; Spokas D; Allen J; Bartlett L; Piccione W; Parrillo JE; Costanzo MR; Calvin JE
J Heart Lung Transplant; 1998 Oct; 17(10):1017-23. PubMed ID: 9811411
[TBL] [Abstract][Full Text] [Related]
27. Left ventricular assist stand-by for high-risk cardiac surgery.
Schmid C; Welp H; Klotz S; Trösch F; Schmidt C; Wilhelm MJ; Scheld HH
Thorac Cardiovasc Surg; 2002 Dec; 50(6):342-6. PubMed ID: 12457310
[TBL] [Abstract][Full Text] [Related]
28. Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump.
Meyns B; Klotz S; Simon A; Droogne W; Rega F; Griffith B; Dowling R; Zucker MJ; Burkhoff D
J Am Coll Cardiol; 2009 Jun; 54(1):79-86. PubMed ID: 19555845
[TBL] [Abstract][Full Text] [Related]
29. Clinical benefits of partial circulatory support in New York Heart Association Class IIIB and Early Class IV patients.
Meyns BP; Simon A; Klotz S; Wittwer T; Schlensak C; Rega F; Burkhoff D
Eur J Cardiothorac Surg; 2011 May; 39(5):693-8. PubMed ID: 20934882
[TBL] [Abstract][Full Text] [Related]
30. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
32. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
[TBL] [Abstract][Full Text] [Related]
33. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
[TBL] [Abstract][Full Text] [Related]
34. Cardiac recovery during mechanical assist device support.
Maybaum S; Kamalakannan G; Murthy S
Semin Thorac Cardiovasc Surg; 2008; 20(3):234-46. PubMed ID: 19038734
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a pulsatile pediatric ventricular assist device in an acute right heart failure model.
Shum-Tim D; Duncan BW; Hraska V; Friehs I; Shin'oka T; Jonas RA
Ann Thorac Surg; 1997 Nov; 64(5):1374-80. PubMed ID: 9386707
[TBL] [Abstract][Full Text] [Related]
36. Ventricular arrhythmias during left ventricular assist device support.
Bedi M; Kormos R; Winowich S; McNamara DM; Mathier MA; Murali S
Am J Cardiol; 2007 Apr; 99(8):1151-3. PubMed ID: 17437746
[TBL] [Abstract][Full Text] [Related]
37. First clinical experience with the Incor left ventricular assist device.
Schmid C; Tjan TD; Etz C; Schmidt C; Wenzelburger F; Wilhelm M; Rothenburger M; Drees G; Scheld HH
J Heart Lung Transplant; 2005 Sep; 24(9):1188-94. PubMed ID: 16143232
[TBL] [Abstract][Full Text] [Related]
38. Continuous cardiac output monitoring with an uncalibrated pulse contour method in patients supported with mechanical pulsatile assist device.
Scolletta S; Miraldi F; Romano SM; Muzzi L
Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):52-6. PubMed ID: 21454314
[TBL] [Abstract][Full Text] [Related]
39. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.
Ochiai Y; McCarthy PM; Smedira NG; Banbury MK; Navia JL; Feng J; Hsu AP; Yeager ML; Buda T; Hoercher KJ; Howard MW; Takagaki M; Doi K; Fukamachi K
Circulation; 2002 Sep; 106(12 Suppl 1):I198-202. PubMed ID: 12354733
[TBL] [Abstract][Full Text] [Related]
40. Similar left and right ventricular sarcomere structure after support with a left ventricular assist device suggests the utility of right ventricular biopsies to monitor left ventricular reverse remodeling.
de Jonge N; Lahpor JR; van Wichen DF; Kirkels H; Gmelig-Meyling FH; van den Tweel JG; Doevendans PA; de Weger RA
Int J Cardiol; 2005 Feb; 98(3):465-70. PubMed ID: 15708181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
